The National Institute of Virology-ICMR Director has praised Bharat Biotech for developing Covid vaccine — Covaxin. Efficacy analysis demonstrated Covaxin to be 77.8 per cent effective against symptomatic Covid and 93.4 per cent effective against severe symptomatic virus. The making of this vaccine entirely on Indian soil is a matter of great pride to every Indian," Abraham said. "Our scientists at ICMR and BBIL have worked tirelessly to deliver a truly effective vaccine of highest international standards. The successful development of Covaxin has consolidated the position of Indian academia and Industry in the global arena," he said.

Source: Mint July 03, 2021 04:41 UTC